• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

膜联蛋白 II 的表达上调是胃癌患者的预后标志物。

Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

机构信息

Department of Surgery, Zhejiang Provincial People’s Hospital, Hangzhou, 310014, China.

出版信息

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.

DOI:10.1186/1477-7819-10-103
PMID:22681645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3433344/
Abstract

BACKGROUND

The role of annexin II in the development and progression of gastric cancer was explored.

METHODS

Real-time PCR was conducted to detect annexin II and S100A6 mRNA expression. Protein expressions of annexin II and S100A6 were also examined by immunohistochemistry in 436 clinicopathologically characterized gastric cancer cases.

RESULTS

The expression of annexin II and S100A6 mRNA differ significantly among gastric tumor tissue and matched non-cancerous gastric mucosa. Protein levels of annexin II and S100A6 were up-regulated in gastric cancer compared with adjacent non-cancerous tissues. High expression of annexin II correlated with age, location of tumor, size of tumor, differentiation, histological type, depth of invasion, vessel invasion, lymph node metastasis, distant metastasis and Tumor, Node, Metastasis (TNM) stage, and also with expression of S100A6. Further multivariate analysis suggested that expression of annexin II and S100A6 were independent prognostic indicators for gastric cancer. Cumulative five-year survival rates of patients with high expression of both annexin II and S100A6 was significantly lower than those with low expression of both.

CONCLUSION

Expression of annexin II in gastric cancer was significantly associated with depth of invasion, lymph node metastasis and distant metastasis, TNM stage, high S100A6 expression, and poor prognosis. Annexin II and S100A6 proteins could be useful prognostic marker to predict tumor progression and prognosis in gastric cancer.

摘要

背景

探讨膜联蛋白 II 在胃癌发生和发展中的作用。

方法

采用实时 PCR 检测 Annexin II 和 S100A6 mRNA 的表达。采用免疫组织化学方法检测 436 例临床病理特征明确的胃癌病例中 Annexin II 和 S100A6 的蛋白表达。

结果

胃癌组织与配对的非癌性胃黏膜组织中 Annexin II 和 S100A6 mRNA 的表达差异有统计学意义。与邻近非癌组织相比，胃癌组织中 Annexin II 和 S100A6 蛋白水平上调。 Annexin II 的高表达与年龄、肿瘤部位、肿瘤大小、分化程度、组织学类型、浸润深度、血管侵犯、淋巴结转移、远处转移、肿瘤淋巴结转移（TNM）分期以及 S100A6 的表达有关。多因素分析表明， Annexin II 和 S100A6 的表达是胃癌的独立预后指标。高表达 Annexin II 和 S100A6 的患者累积五年生存率明显低于低表达 Annexin II 和 S100A6 的患者。

结论

胃癌中 Annexin II 的表达与浸润深度、淋巴结转移和远处转移、TNM 分期、高 S100A6 表达及预后不良显著相关。 Annexin II 和 S100A6 蛋白可作为预测胃癌肿瘤进展和预后的有用预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/cb9f62887850/1477-7819-10-103-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/58d1b7ca4725/1477-7819-10-103-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/e8de343efdd4/1477-7819-10-103-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/5f0481f84433/1477-7819-10-103-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/cb9f62887850/1477-7819-10-103-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/58d1b7ca4725/1477-7819-10-103-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/e8de343efdd4/1477-7819-10-103-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/5f0481f84433/1477-7819-10-103-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcb/3433344/cb9f62887850/1477-7819-10-103-4.jpg

相似文献

1
Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.膜联蛋白 II 的表达上调是胃癌患者的预后标志物。
World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.
2
High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.S100A4 的高表达与胃癌患者的淋巴结转移和不良预后相关。
Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z. Epub 2009 Oct 10.
3
[Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer].S100A6对胃癌侵袭转移的调控机制研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Nov;16(11):1096-101.
4
Beclin 1 expression is an independent prognostic factor for gastric carcinomas.Beclin 1表达是胃癌的一个独立预后因素。
Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.
5
Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.黏附蛋白 Bves 的异常表达与胃癌的进展和不良预后相关。
Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x. Epub 2011 Nov 23.
6
Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.异常的肌浆网Ca2+-ATP酶3（SERCA3）表达与胃癌的发病机制、侵袭、转移及预后密切相关。
Tumour Biol. 2012 Dec;33(6):1845-54. doi: 10.1007/s13277-012-0444-x. Epub 2012 Sep 5.
7
[Expression of S100A6 in primary and metastatic human gastric cancer].[S100A6在原发性和转移性人类胃癌中的表达]
Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):506-10.
8
Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.SOCS-1和SOCS-3的低表达是胃癌患者预后不良的指标。
J Cancer Res Clin Oncol. 2015 Mar;141(3):443-52. doi: 10.1007/s00432-014-1838-5. Epub 2014 Sep 28.
9
NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.NEDD9 过表达与胃癌的进展和预后相关。
Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4. Epub 2014 Jan 28.
10
S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.S100 钙结合蛋白 A4 是胃癌预后不良的一个新的独立预后因素。
Oncol Rep. 2013 Jul;30(1):111-8. doi: 10.3892/or.2013.2419. Epub 2013 Apr 23.

引用本文的文献

1
The value of ATAD3A as a potential biomarker for bladder cancer.ATAD3A 作为膀胱癌潜在生物标志物的价值。
Cancer Med. 2023 Dec;12(24):22395-22406. doi: 10.1002/cam4.6759. Epub 2023 Nov 28.
2
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles.使用氯毒素纳米颗粒治疗胶质母细胞瘤和神经母细胞瘤癌症的诊断与治疗方法。
Cancers (Basel). 2023 Jun 28;15(13):3388. doi: 10.3390/cancers15133388.
3
Annexin A2 and Kidney Diseases.膜联蛋白A2与肾脏疾病

本文引用的文献

1
Annexin A2 promotes glioma cell invasion and tumor progression.膜联蛋白 A2 促进神经胶质瘤细胞侵袭和肿瘤进展。
J Neurosci. 2011 Oct 5;31(40):14346-60. doi: 10.1523/JNEUROSCI.3299-11.2011.
2
The role of annexin A2 in tumorigenesis and cancer progression.膜联蛋白A2在肿瘤发生和癌症进展中的作用。
Cancer Microenviron. 2011 Aug;4(2):199-208. doi: 10.1007/s12307-011-0064-9. Epub 2011 Mar 5.
3
Upregulation of connexin 30 in intestinal phenotype gastric cancer and its reduction during tumor progression.肠型胃癌中连接蛋白 30 的上调及其在肿瘤进展过程中的减少。
Front Cell Dev Biol. 2022 Sep 2;10:974381. doi: 10.3389/fcell.2022.974381. eCollection 2022.
4
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.姜黄素类化合物作为侵袭性癌症中上皮-间质转化的调节剂：基于恶性间皮瘤研究贡献的分子靶点综述
Front Pharmacol. 2022 Jul 8;13:934534. doi: 10.3389/fphar.2022.934534. eCollection 2022.
5
Advances in cancer treatment: a new therapeutic target, Annexin A2.癌症治疗进展：一个新的治疗靶点，膜联蛋白A2。
J Cancer. 2021 Apr 24;12(12):3587-3596. doi: 10.7150/jca.55173. eCollection 2021.
6
Defective membrane repair machinery impairs survival of invasive cancer cells.缺陷的膜修复机制会损害侵袭性癌细胞的存活。
Sci Rep. 2020 Dec 11;10(1):21821. doi: 10.1038/s41598-020-77902-5.
7
Expression and Clinical Significance of MMP-28 in Bladder Cancer.膀胱癌中 MMP-28 的表达及临床意义。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820974017. doi: 10.1177/1533033820974017.
8
Biomarkers of tumor invasiveness in proteomics (Review).蛋白质组学中肿瘤侵袭性的生物标志物（综述）。
Int J Oncol. 2020 Aug;57(2):409-432. doi: 10.3892/ijo.2020.5075. Epub 2020 May 28.
9
ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells.膜联蛋白A2沉默抑制胃癌细胞的增殖、侵袭和迁移。
J Oncol. 2019 May 2;2019:4035460. doi: 10.1155/2019/4035460. eCollection 2019.
10
Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma.钙通道α2δ1亚基作为诊断肝细胞癌的新型生物标志物。
Cancer Biol Med. 2018 Feb;15(1):52-60. doi: 10.20892/j.issn.2095-3941.2017.0167.
Pathobiology. 2010;77(5):241-8. doi: 10.1159/000314966. Epub 2010 Nov 29.
4
Annexin A2 as a differential diagnostic marker of hepatocellular tumors.膜联蛋白 A2 作为肝细胞肿瘤的鉴别诊断标志物。
Pathol Res Pract. 2011 Jan 15;207(1):8-14. doi: 10.1016/j.prp.2010.09.007. Epub 2010 Oct 23.
5
Characterization of phosphoproteins in gastric cancer secretome.胃癌外泌体中磷酸化蛋白质的鉴定。
OMICS. 2011 Jan-Feb;15(1-2):83-90. doi: 10.1089/omi.2010.0056. Epub 2010 Aug 20.
6
Unique S100 target protein interactions.独特的S100靶蛋白相互作用。
Gen Physiol Biophys. 2009;28 Spec No Focus:F39-46.
7
SPARC is associated with gastric cancer progression and poor survival of patients.SPARC 与胃癌的进展和患者的不良预后相关。
Clin Cancer Res. 2010 Jan 1;16(1):260-8. doi: 10.1158/1078-0432.CCR-09-1247. Epub 2009 Dec 22.
8
Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.YKL-40的过表达是胃癌的一个独立预后标志物。
Hum Pathol. 2009 Dec;40(12):1790-7. doi: 10.1016/j.humpath.2009.07.005. Epub 2009 Sep 17.
9
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility.S100A6在胰腺癌细胞中与膜联蛋白2结合，并促进胰腺癌细胞的运动。
Br J Cancer. 2009 Oct 6;101(7):1145-54. doi: 10.1038/sj.bjc.6605289. Epub 2009 Sep 1.
10
Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma.膜联蛋白II的过表达影响多发性骨髓瘤的增殖、凋亡、侵袭及促血管生成因子的产生。
Int J Hematol. 2009 Sep;90(2):177-185. doi: 10.1007/s12185-009-0356-8. Epub 2009 Jul 8.